In March and early April of 2009, the pandemic influenza A/H1N1 2009 virus (H1N1 2009) was detected in Mexico and the United States, followed by a rapid worldwide person-toperson spread (1, 6) . The detection of influenza virus-specific RNA via reverse transcriptase PCR (RT-PCR) is the current method of choice for the detection of influenza virus (3, 5) . (Fig. 1) . Among the 117 clinical specimens, only one specimen (seasonal influenza A H1N1 virus) was weakly positive for H1N1 2009 by RAT, and the others were negative.
The RAT for the detection of H1N1 2009 revealed a broad range of sensitivity and specificity (9.6 to ϳ75% and 80 to ϳ100%, respectively) (4, 5, 7, 8) . Because of its low sensitivity, the clinical utility of RAT remains a subject of debate (2, 8, 9) . Our results show that the new RAT features relatively high sensitivity for the detection of H1N1 2009. We presume that the difference of antibody affinity and targeting sites (hemagglutinin and nucleoprotein) of detection components may affect different sensitivities. Additionally, in the majority of cases, the new RAT can distinguish between seasonal influenza virus and H1N1 2009, although our results are preliminary due to the very limited number of samples, and further specificity testing of the RAT with more seasonal influenza viruses may be required. Because more than 99% of the current seasonal H1 strains are resistant to oseltamivir, diagnostic tests to distinguish the pandemic strain from seasonal influenza virus may be important for clinical management (9) . Also, RAT has the advantage of providing rapid results. In our laboratory, the average turnaround times of RAT and realtime RT-PCR were 0.9 and 14.9 h, respectively. 
